When a Normal PaCO2 in Asthma Is a Warning
A 24-year-old woman with a 12-year history of asthma presents with a 3-day history of a viral upper respiratory infection and worsening wheeze. She has used her albuterol inhaler at 8 puffs every 4 hours for 2 days with no relief and has not slept. On arrival she is sitting forward, speaking in 2- to 3-word phrases, RR 34, HR 134, SpO2 91% on room air, and peak expiratory flow 120 L/min against a personal best of 550 L/min. She receives continuous albuterol 10 mg/h for 60 minutes, three doses of ipratropium 0.5 mg, and methylprednisolone 125 mg intravenously. Two hours later she is drowsy but arousable, RR 30, SpO2 93% on 4 L/min nasal cannula, and breath sounds are nearly silent at both bases. Arterial blood gas shows pH 7.29, PaCO2 49 mmHg, PaO2 70 mmHg, and HCO3 23 mEq/L. The team asks whether to start bilevel noninvasive ventilation or prepare for intubation.
1. Interpret the blood gas. Why is a PaCO2 of 49 mmHg more concerning in this patient than in a patient with COPD?
Read the worked answer
In acute asthma the patient hyperventilates, so the expected PaCO2 is low, typically 25 to 35 mmHg, with a respiratory alkalosis. A PaCO2 that rises into the normal range or above it means the patient can no longer sustain the work of breathing. It is a sign of fatigue and impending failure, not a reassuring normal value.
In COPD with chronic hypercapnia, the kidneys retain bicarbonate over days, so pH is near normal and HCO3 is elevated. Here HCO3 is 23 mEq/L, which is not elevated, and pH is 7.29. That combination confirms an acute respiratory acidosis without metabolic compensation. The PaO2 of 70 mmHg on 4 L/min is also inadequate, and the alveolar-arterial gradient is widened, indicating significant ventilation-perfusion mismatch.
Combine the gas with the examination: drowsiness, silent chest, accessory muscle use, and a peak flow of 120 L/min against a best of 550. This is a pre-arrest picture.
2. Should the team start noninvasive ventilation or prepare for intubation? Justify your answer, including adjunctive therapy.
Read the worked answer
Prepare for intubation. Noninvasive ventilation is not appropriate here. The patient is drowsy, cannot reliably protect her airway, and has a silent chest indicating minimal airflow. Positive pressure in a severely hyperinflated patient can worsen air trapping and cause hypotension or barotrauma, and a trial of noninvasive ventilation would delay a needed airway.
While preparing, give magnesium sulfate 2 g intravenously over about 20 minutes; it can reduce the need for intubation but must not postpone airway management. Continue continuous albuterol and ipratropium and ensure systemic steroids are given.
For induction, ketamine at 1 to 2 mg/kg is a reasonable choice because it bronchodilates and supports blood pressure. Use a large endotracheal tube, 8.0 mm or greater, to reduce resistance and allow bronchoscopy if needed. Preoxygenate, have vasopressors ready, and anticipate hypotension from auto-PEEP immediately after intubation.
3. What ventilator and monitoring strategy do you anticipate after intubation in this patient?
Read the worked answer
The main risk is dynamic hyperinflation. Set a low respiratory rate, around 8 to 10 breaths per minute, with high inspiratory flow of 70 to 90 L/min and a long expiratory time, targeting an inspiratory-to-expiratory ratio of at least 1:4. Use a tidal volume of 6 to 8 mL/kg predicted body weight and modest PEEP, typically 0 to 5 cmH2O, then reassess. Accept permissive hypercapnia with a pH above roughly 7.20 rather than increasing rate and worsening trapping.
Measure intrinsic PEEP with an expiratory hold, and compare inspired and expired tidal volumes; an expired volume lower than inspired indicates trapping. Watch peak and plateau pressures and blood pressure. Hypotension after induction should prompt a fluid bolus and a brief disconnection to allow full exhalation.
Give bronchodilators through the circuit, recheck an arterial blood gas within 30 minutes, and monitor for barotrauma. Wean sedation daily once bronchospasm is controlled.